What is the approximate long-term survival rate for AML?

Prepare for the Adult-Gerontology Acute Care Nurse Practitioner Test. Study with interactive quizzes and detailed explanations. Boost your exam readiness with our diverse question formats and in-depth content coverage.

Multiple Choice

What is the approximate long-term survival rate for AML?

In AML, prognosis isn’t one-size-fits-all; long-term survival depends a lot on risk factors like age, fitness, and especially cytogenetics and molecular abnormalities. In younger, fit adults who have favorable-risk features, intensive induction chemotherapy followed by consolidation—and sometimes allogeneic stem cell transplantation for higher-risk disease—can lead to long-term remission and possible cure. In those select groups, long-term survival can approach the higher end, around 70–80%. By contrast, the overall picture for the broader AML population, especially older patients or those with adverse cytogenetics, is much poorer. So the 80% figure represents the potential for long-term survival in a favorable subset, rather than a universal rate for all AML patients.

In AML, prognosis isn’t one-size-fits-all; long-term survival depends a lot on risk factors like age, fitness, and especially cytogenetics and molecular abnormalities. In younger, fit adults who have favorable-risk features, intensive induction chemotherapy followed by consolidation—and sometimes allogeneic stem cell transplantation for higher-risk disease—can lead to long-term remission and possible cure. In those select groups, long-term survival can approach the higher end, around 70–80%. By contrast, the overall picture for the broader AML population, especially older patients or those with adverse cytogenetics, is much poorer. So the 80% figure represents the potential for long-term survival in a favorable subset, rather than a universal rate for all AML patients.

More practice questions